Latest News about Jazz
Recent news which mentions Jazz
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
August 18, 2022
From Benzinga
Jazz' Epidiolex, The Only FDA-Approved CBD Drug, Enters Phase 3 Trial Evaluating Its Effects In Patients With Myoclonic-Atonic Seizures
August 18, 2022
Tickers
JAZZ
From Benzinga
Why Axsome Therapeutics Topped the Market Today
August 09, 2022
From Motley Fool
Jazz Pharmaceuticals' Return On Capital Employed Insights
August 08, 2022
Tickers
JAZZ
From Benzinga
From Benzinga
From Motley Fool
7 Biotech Stocks to Buy for Q3
July 18, 2022
From InvestorPlace
From Benzinga
Why BioXcel Therapeutics Was a Winner This Week
July 08, 2022
From Motley Fool
From Motley Fool
Brazilian Fund Invests $19M In US Cannabis Stocks
July 05, 2022
From Benzinga
What Bear Market? These 2 Stocks Are Killing It.
July 01, 2022
From Motley Fool
From Benzinga
Jazz Pharma's Cannabidiol Mixture Spray Misses Primary Goal In Multiple Sclerosis Spasticity
June 28, 2022
Tickers
JAZZ
From Benzinga
From Motley Fool
This Pharmaceutical Company Is Moving Beyond CBD
June 23, 2022
From Benzinga
Leisuretown: Diplo And Rob Dyrdek's New Cannabis Seltzers Launch In California Via Agreement With HERBL
June 23, 2022
From Benzinga
3 Stocks That Could Double by 2025
June 19, 2022
From Motley Fool
2 Cheap Stocks to Buy Right Now
June 16, 2022
From Motley Fool
2 Top Biotech Stocks Ready for Bull Runs
June 15, 2022
From Motley Fool
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.